Management of penicillamine nephropathy in Wilson's disease: a new chelating agent.
Walshe, J M
Management of penicillamine nephropathy in Wilson's disease: a new chelating agent. [electronic resource] - Lancet (London, England) Dec 1969 - 1401-2 p. digital
Publication Type: Journal Article
0140-6736
10.1016/s0140-6736(69)90940-4 doi
Adolescent
Chelating Agents--therapeutic use
Chlorides
Copper--metabolism
Ethylenediamines--therapeutic use
Hepatolenticular Degeneration--drug therapy
Humans
Male
Nephrotic Syndrome--chemically induced
Neurologic Manifestations
Penicillamine--adverse effects
Management of penicillamine nephropathy in Wilson's disease: a new chelating agent. [electronic resource] - Lancet (London, England) Dec 1969 - 1401-2 p. digital
Publication Type: Journal Article
0140-6736
10.1016/s0140-6736(69)90940-4 doi
Adolescent
Chelating Agents--therapeutic use
Chlorides
Copper--metabolism
Ethylenediamines--therapeutic use
Hepatolenticular Degeneration--drug therapy
Humans
Male
Nephrotic Syndrome--chemically induced
Neurologic Manifestations
Penicillamine--adverse effects